Article Text

Download PDFPDF
Progress in diagnosis and treatment of bipolar disorder among children and adolescents: an international perspective
  1. Robert L Findling1,
  2. Ekaterina Stepanova1,
  3. Eric A Youngstrom2,
  4. Andrea S Young1
  1. 1 Child and Adolescent Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA
  2. 2 Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
  1. Correspondence to Dr Ekaterina Stepanova, Child and Adolescent Psychiatry, Johns Hopkins University, Baltimore, MD 21287, USA; estepan2{at}jhmi.edu

Footnotes

  • Contributors RLF, ES and ASY conducted the original literature search and drafted the manuscript. EAY performed additional literature review and substantially aided in revising the article for resubmission.

  • Funding ASY was partially funded by aNARSAD Young Investigator Grant from the Brain & Behavior ResearchFoundation .

  • Competing interests RLF has received research funding for grant/research support and/or as a consultant from the following commercial organisations: Aevi, Akili, Alcobra, Amerex, Am Acad CAP, American Psychiatric Press, Bracket, Epharma Solutions, Forest, Genentech, Guilford Press, Ironshore, Johns Hopkins U Press, KemPharm, Lundbeck, Merck, NIH, Neurim, Nuvelution, Otsuka, PCORI, Pfizer, Physicians Postgraduate Press, Purdue, Roche, Sage, Shire, Sunovion, Supernus Pharmaceuticals, Syneurx, Teva, Touchpoint, Tris, Validus, WebMD. ES and ASY have received research funding from PsychNostics, LLC, and Supernus Pharmaceuticals. EAY has consulted about psychological assessment with Pearson, Janssen, Joe Startup Technologies and Western Psychological Services; he has received royalties from the American Psychological Association and Guilford Press.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors RLF, ES and ASY conducted the original literature search and drafted the manuscript. EAY performed additional literature review and substantially aided in revising the article for resubmission.

  • Funding ASY was partially funded by aNARSAD Young Investigator Grant from the Brain & Behavior ResearchFoundation .

  • Competing interests RLF has received research funding for grant/research support and/or as a consultant from the following commercial organisations: Aevi, Akili, Alcobra, Amerex, Am Acad CAP, American Psychiatric Press, Bracket, Epharma Solutions, Forest, Genentech, Guilford Press, Ironshore, Johns Hopkins U Press, KemPharm, Lundbeck, Merck, NIH, Neurim, Nuvelution, Otsuka, PCORI, Pfizer, Physicians Postgraduate Press, Purdue, Roche, Sage, Shire, Sunovion, Supernus Pharmaceuticals, Syneurx, Teva, Touchpoint, Tris, Validus, WebMD. ES and ASY have received research funding from PsychNostics, LLC, and Supernus Pharmaceuticals. EAY has consulted about psychological assessment with Pearson, Janssen, Joe Startup Technologies and Western Psychological Services; he has received royalties from the American Psychological Association and Guilford Press.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.